Trial Details
COMPLETEDBasic Information
| Clinical ID | c1371 |
|---|---|
| Identifier | NCT01839214 |
| Trial Title | A Study to Evaluate the Efficacy and Safety of VB-201 in Patients With Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis |
| Interventions | DRUG: VB-201 160mg|DRUG: Placebo |
Participant Information
| Sponsor | Vascular Biogenics Ltd. operating as VBL Therapeutics |
|---|---|
| City | Sofia |
| Country/Region | Bulgaria |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2025-01-13 |
|---|---|
| Primary Completion Date | 2025-11-14 |
| Completion Date | 2025-11-14 |